June 24, 2017 12:48 AM ET

Biotechnology

Company Overview of Abcodia Ltd.

Company Overview

Abcodia Ltd. engages in the discovery and validation of molecular biomarkers for disease diagnosis and screening. It offers Roca Test solutions for early ovarian cancer detection to customers in Arizona, Illinois, Massachusetts, New Jersey, Texas, Georgia, Michigan, Missouri, North Carolina, Nevada, Ohio, Oregon, Virginia, Washington, Wisconsin, the District of Columbia, and the United Kingdom. The company was incorporated in 2010 and is based in London, United Kingdom.

The Network Building

97 Tottenham Court Road

London,  W1T 4TP

United Kingdom

Founded in 2010

Key Executives for Abcodia Ltd.

Chief Executive officer
President of North America
Compensation as of Fiscal Year 2016.

Abcodia Ltd. Key Developments

Abcodia Announces Expanded U.S. Availability of the Roca Test for Early Ovarian Cancer Detection

Abcodia announced expanded U.S. availability of the ROCA Test. Following an initial U.S. launch in Arizona, Illinois, Massachusetts, New Jersey and Texas, the ROCA Test is now available in nine additional states (Georgia, Michigan, Missouri, North Carolina, Nevada, Ohio, Oregon, Virginia, Washington, Wisconsin) and the District of Columbia. The ROCA Test fills a major unmet need in the early detection of ovarian cancer.

Abcodia Ltd. Announces Initial U.S. Availability of the ROCA® Test to Aid in the Early Detection of Ovarian Cancer

Abcodia Ltd. announced the availability of the ROCA® Test for use by physicians in five U.S. states: Arizona, Illinois, Massachusetts, New Jersey and Texas. The test is already being used in the U.K. by private clinics and will become available in additional U.S. states throughout 2016. The ROCA Test, available as a service from Abcodia’s testing laboratory, uses a number of clinical variables such as age, menopausal status and serial blood measurements of biomarker protein, CA-125 to assess the likelihood that a woman has ovarian cancer.

Abcodia Ltd. Appoints Richard A. Sandberg to its Board of Directors

Abcodia Ltd. announced the appointment of Richard A. "Dick" Sandberg to its board of directors. He currently serves as chairman of the board of Oxford Immunotec Global, plc.

Similar Private Companies By Industry

Company Name Region
Abcellute Ltd. Europe
Abcodia Ltd. Europe
Abeterno Ltd. Europe
Abgentis Limited Europe
Achilles Therapeutics Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Abcodia Ltd., please visit www.abcodia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.